Works matching IS 00912700 AND DT 2023 AND VI 63 AND IP 12


Results: 15
    1
    2
    3
    4
    5
    6

    Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram‐Negative Bacterial Infections: A Phase 1b, Open‐Label, Single‐Dose Clinical Trial.

    Published in:
    Journal of Clinical Pharmacology, 2023, v. 63, n. 12, p. 1387, doi. 10.1002/jcph.2334
    By:
    • Bradley, John S.;
    • Makieieva, Nataliia;
    • Tøndel, Camilla;
    • Roilides, Emmanuel;
    • Kelly, Matthew S.;
    • Patel, Munjal;
    • Vaddady, Pavan;
    • Maniar, Alok;
    • Zhang, Ying;
    • Paschke, Amanda;
    • Chen, Luke F.
    Publication type:
    Article
    7

    JAK Inhibitors in Solid Organ Transplantation.

    Published in:
    Journal of Clinical Pharmacology, 2023, v. 63, n. 12, p. 1330, doi. 10.1002/jcph.2325
    By:
    • Assadiasl, Sara;
    • Mojtahedi, Hanieh;
    • Nicknam, Mohammad Hossein
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    Issue Information.

    Published in:
    Journal of Clinical Pharmacology, 2023, v. 63, n. 12, p. 1301, doi. 10.1002/jcph.1906
    Publication type:
    Article
    15